. Departamento de Ensino e Pesquisa, Hospital de Câncer de Pernambuco, Recife (PE) Brasil.
. Departamento de Oncologia, Instituto de Medicina Integral Professor Fernando Figueira, Recife (PE) Brasil.
J Bras Pneumol. 2020 Jan 20;46(1):e20180251. doi: 10.1590/1806-3713/e20180251. eCollection 2020.
To characterize the clinical and histological profile, as well as treatment patterns, of patients with early-stage, locally advanced (LA), or advanced/metastatic (AM) lung cancer, diagnosed between 2000 and 2014, in Brazil.
This was an analytical cross-sectional epidemiological study employing data obtained for the 2000-2014 period from the hospital cancer registries of two institutions in Brazil: the José Alencar Gomes da Silva National Cancer Institute, in the city of Rio de Janeiro; and the São Paulo Cancer Center Foundation, in the city of São Paulo.
We reviewed the data related to 73,167 patients with lung cancer. The proportions of patients with early-stage, LA, and AM lung cancer were 13.3%, 33.2%, and 53.4%, respectively. The patients with early-stage lung cancer were older and were most likely to receive a histological diagnosis of adenocarcinoma; the proportion of patients with early-stage lung cancer remained stable throughout the study period. In those with LA lung cancer, squamous cell carcinoma predominated, and the proportion of patients with LA lung cancer decreased significantly over the period analyzed. Those with AM lung cancer were younger and were most likely to have adenocarcinoma; the proportion of patients with AM lung cancer increased significantly during the study period. Small cell carcinoma accounted for 9.2% of all cases. In our patient sample, the main treatment modality was chemotherapy.
It is noteworthy that the frequency of AM lung cancer increased significantly during the study period, whereas that of LA lung cancer decreased significantly and that of early-stage lung cancer remained stable. Cancer treatment patterns, by stage, were in accordance with international guidelines.
描述 2000 年至 2014 年间在巴西诊断的早期、局部晚期(LA)或晚期/转移性(AM)肺癌患者的临床和组织学特征以及治疗模式。
这是一项分析性的横断面流行病学研究,使用了巴西两家机构(里约热内卢的若泽·阿尔坎加·戈麦斯·达席尔瓦国家癌症研究所和圣保罗癌症中心基金会)的医院癌症登记处 2000-2014 年期间获得的数据。
我们回顾了与 73167 例肺癌患者相关的数据。早期、LA 和 AM 肺癌患者的比例分别为 13.3%、33.2%和 53.4%。早期肺癌患者年龄较大,最有可能接受腺癌的组织学诊断;早期肺癌患者的比例在整个研究期间保持稳定。在 LA 肺癌患者中,鳞状细胞癌更为常见,且在分析期间 LA 肺癌患者的比例显著下降。AM 肺癌患者年龄较小,且最有可能患有腺癌;在研究期间 AM 肺癌患者的比例显著增加。小细胞癌占所有病例的 9.2%。在我们的患者样本中,主要的治疗方式是化疗。
值得注意的是,在研究期间,AM 肺癌的频率显著增加,而 LA 肺癌的频率显著下降,早期肺癌的频率保持稳定。根据分期,癌症治疗模式符合国际指南。